CIPO Patents = 1

EPO Patents = 4

Forward Citations = 13

Loading Chart...

7 inventors (with patents filed for the assignee):

Shawn DeFrees (3 out of 61 patents)

Zhi-Guang Wang (2 out of 6 patents)

Karl Frank Johnson (2 out of 14 patents)

4. Stephen G Withers (1 out of 20 patents)

5. Mark Vaughan (1 out of 2 patents)

6. Zhi Guang Wang (1 out of 1 patent)

7. Shawn A Defrees (1 out of 1 patent)

8. Karl F Johnson (1 patent)

4 patents: Sort by Forward Citations

1. 9068208 - Mutant endoglycoceramidases with enhanced synthetic activity (2015-06-30),

2. 7932236 - Glycolipids (2011-04-26),

3. 7888331 - Ganglioside compositions and methods of use (2011-02-15),

4. 7842677 - Synthetic ganglioside derivatives and compositions thereof (2010-11-30),

Seneb Biosciences, Inc. is a leading biotechnology company focused on developing innovative therapies for various diseases. Our cutting-edge research and development efforts aim to revolutionize the field of biomedicine and improve patient outcomes. With a dedicated team of scientists and industry experts, we are committed to pushing the boundaries of science and bringing life-changing treatments to those in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#7 in North Wales, PA

#2,183 in Pennsylvania

#59,059 in US

North Wales, PA, United States of America

Seneb Biosciences, Inc.

Forward Citations = 13

7 inventors:

Shawn DeFrees (3 out of 61 patents)

Zhi-Guang Wang (2 out of 6 patents)

Karl Frank Johnson (2 out of 14 patents)

4. Stephen G Withers (1 out of 20 patents)

5. Mark Vaughan (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com